A group of drug dealers withdrew from the market.

Judging from the contents of the announcement, these pharmaceutical companies cancel the "Drug Business License" are active applications, the reason is that the company is its termination of the operation of drugs or closure.
fact, for pharmaceutical companies to voluntarily cancel the "drug production license" or "drug business license", for the time being, is nothing new.
should say that this is a common phenomenon in the industry, and many enterprises have voluntarily applied for cancellation.
according to the incomplete statistics of Cypress Blue, in the past two years, many pharmaceutical companies and drug dealers have voluntarily applied to cancel the "Drug Production License" or "Drug Business License".
in recent years, the pharmaceutical industry policy environment is changing, whether it is strict supervision, drug bidding, medical insurance fees, or consistent evaluation, will prompt pharmaceutical companies to adjust their product structure to meet market demand.
many pharmaceutical companies face can not be properly adjusted, their own reform can not keep up with the situation, can only sell factories or seek cooperation.
success is the equivalent of finding a back footing and continuing to grow, while those who have not been successful in mergers and acquisitions are bound to be out.
for commercial companies, they are under pressure from a two-vote system, distribution rate requirements, and hospital rebates.
face severe penalties for non-compliance with delivery standards.
warning, suspend transactions, or even disqualify delivery, and include bad records.
addition, it is understood that the net gross margin of 5%-8%, but medical institutions generally have a longer repayment cycle, coupled with financial management costs, net sales margin is basically around 1%.
Today, the relevant departments of the downstream terminal supervision is more stringent, commercial paper management is more stringent, coupled with the hospital repayment problem, many small and medium-sized drug dealers are also facing huge financial pressure, while facing the question of whether to continue to operate. More than
drugstore chains did not do the same on July 13, Shaanxi Provincial Drug Administration issued "on the cancellation of the Ganzhou Pharmaceutical Building Chain Co., Ltd. and other enterprises drug business license announcement."
from the contents of the announcement, these drugstore chains cancel the "drug business license", is also an active application.
for pharmaceutical retail enterprises, in recent years, the requirements are more and more stringent, fly inspection is more and more frequent.
, according to the Shaanxi Drug Administration recently released the "drug retail enterprise flight inspection results notice" shows that many pharmacies in the course of business there are still many problems.
From April 22 to 26, and from May 27 to June 3, the Shaanxi Provincial Drug Administration organized flight inspections of some drug retail enterprises in the province and found that 39 pharmaceutical retail enterprises had serious violations of the Code of Quality Management of Drug Operations in the course of their operations.
the main problems found in the inspection include: 26 enterprises do not set up drug traceability system according to regulations; 21 enterprises sell prescription drugs without the examination and sale of practicing pharmacists; 20 enterprises do not sell specially managed drugs in strict accordance with the relevant provisions; 16 enterprises do not obtain invoices from suppliers in a timely manner; 15 enterprises cannot provide supplier qualifications; 13 enterprises do not sell prescription drugs on prescription; 7 enterprises have over-range drugs; 4 enterprises do not meet the requirements for refrigerated drug storage; 3 enterprises sell expired medicines; and 1 enterprise does not have tickets, accounts and goods.
with the increasing competition in the pharmaceutical industry, the competition between retail pharmacies is also extremely fierce.
, according to Seber Blue, many retail pharmacies are currently in a situation of not making money or losing money.
And for chain pharmacies, each store is the most basic source of profits of chain enterprises, store management accounted for more than 80% of the day-to-day management of retail chain enterprises, with the market competition is getting bigger and bigger, the management level of chain pharmacies is urgent.
, pharmaceutical companies, drug dealers, and retail pharmacies are faced with the problems of transformation and development.
This is an era of constantly updated iterations, once can not adapt and adjust to keep up with the requirements of policy and industry development, can only seek mergers and acquisitions, seek cooperation, or take the initiative to write off, completely eliminated by the market.
.